Concepedia

Tim J A Hutten

TJ

Statistics

Publications

6

Citations

235

H-Index

6

Active since

2013

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Radboud Institute for Molecular Life Sciences

Leiden University Medical Center

University Medical Center Utrecht

Tim J A Hutten is an author at Radboud University Medical Center specializing in immunotherapy, cancer immunotherapy, and life sciences.

ORCID

Publications per year

2013–2020

6

Publications

6

The Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes Human Plasmacytoid and Myeloid Dendritic Cell Development from CD34 <sup>+</sup> Hematopoietic Progenitor Cells

Soley Thordardottir, Basav N. Hangalapura, Tim J A Hutten et al. · Stem Cells and Development · 2013 · 65 citations

, , +14

Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation

Tim J A Hutten, Wieger J. Norde, Rob Woestenenk et al. · Biology of Blood and Marrow Transplantation · 2017 · 54 citations · Full text

, , +17

CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses

Tim J A Hutten, Soley Thordardottir, Hanny Fredrix et al. · The Journal of Immunology · 2016 · 45 citations

, , +17

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

Johan M.J. Van den Bergh, Evelien Smits, Zwi Berneman et al. · Cancer Immunology Research · 2017 · 41 citations

, , +17

PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity

Diede van Ens, Charlotte M. Mousset, Tim J A Hutten et al. · Bone Marrow Transplantation · 2020 · 18 citations

, , +16

1–5 of 6